Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00018460 · ClinicalTrials.gov registry record · NA

Anticoagulation, Vitamins, and Endothelial Function

A NA study of Cardiovascular Diseases, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
1
Study location

NCT00018460 is a NA study of Cardiovascular Diseases that has completed, run by US Department of Veterans Affairs. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00018460, a NA study of Cardiovascular Diseases, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
1
Study location

Study Summary

Determine whether low or high dose B vitamin therapy will lower homocysteine and thrombomodulin in patients anticoagulated with warfarin.

Conditions Studied

Interventions

  • DRUG Vitamin B

Study Locations (1)

Maryland

  • VA Maryland Health Care System - Baltimore

Trial Details

FieldValue
Start Date 1999-04
Est. Completion 2002-03
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00018460

The ClinicalTrials.gov registry entry for NCT00018460 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Vitamin B is the first listed.

NCT00018460 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00018460 about?

NCT00018460 is a clinical study titled "Anticoagulation, Vitamins, and Endothelial Function". Determine whether low or high dose B vitamin therapy will lower homocysteine and thrombomodulin in patients anticoagulated with warfarin.

What is the current status of trial NCT00018460?

This trial is currently completed. It is a NA study. The study started on 1999-04. Estimated completion is 2002-03.

What conditions does trial NCT00018460 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT00018460?

The interventions under investigation include: Vitamin B (DRUG).

Who is sponsoring clinical trial NCT00018460?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00018460 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.